Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-21

Clinical Trial Update: Study on the Efficacy and Safety of Low-dose CTX as Maintenance Therapy for MM Unsuitable for Transplantation [Phase 2, Phase 3]

View source ↗

Summary

A multi-phase clinical trial assessing low-dose CTX as maintenance therapy for newly diagnosed multiple myeloma patients unsuitable for transplantation; current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CTX

Snippet

Sponsor: Jinling Hospital, China | Conditions: Newly Diagnosed Multiple Myeloma | Phase 2, Phase 3 | Status: UNKNOWN